Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy

Código QR

Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy

Danial Mohabati,1,2 Elon HC van Dijk,1 Thomas J van Rijssen,1 Eiko K de Jong,3 Myrte B Breukink,3 Jose P Martinez-Ciriano,4 Greet Dijkman,1 Carel B Hoyng,3 Sascha Fauser,5 Suzanne Yzer,4 Camiel JF Boon1,6 1Department of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands; 2Depa...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Mohabati D, van Dijk EHC, van Rijssen TJ, de Jong EK, Breukink MB, Martinez-Ciriano JP, Dijkman G, Hoyng CB, Fauser S, Yzer S, Boon CJF
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2018
Materias:	Chronic central serous chorioretinopathy photodynamic therapy posterior cystoid retinal degeneration severe phenotype therapeutic outcome Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/1ac480e105f84b34b1447fb7d96f40d8
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Clinical characteristics and long-term visual outcome of severe phenotypes of chronic central serous chorioretinopathy
por: Mohabati D, et al.
Publicado: (2018)

Risk of Recurrence and Transition to Chronic Disease in Acute Central Serous Chorioretinopathy
por: Mohabati D, et al.
Publicado: (2020)

Central Serous Chorioretinopathy: Pathogenesis and Management
por: Semeraro F, et al.
Publicado: (2019)

Changes of outer retinal microstructures after photodynamic therapy for chronic central serous chorioretinopathy
por: Shimizu K, et al.
Publicado: (2017)

Photodynamic therapy combined with antivascular endothelial growth factor treatment for recalcitrant chronic central serous chorioretinopathy
por: Asahi MG, et al.
Publicado: (2017)

Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life
por: Breukink MB, et al.
Publicado: (2016)

Photodynamic therapy in combination with intravitreal ziv-aflibercept and aflibercept injection in patients with chronic or repeatedly recurrent acute central serous chorioretinopathy: a single-center retrospective study
por: Doepfner JM, et al.
Publicado: (2018)

Long-term outcomes in half-dose verteporfin photodynamic therapy for chronic central serous retinopathy
por: Dhirani NA, et al.
Publicado: (2017)

Features of emotional and personality status of patients with central serous chorioretinopathy
por: A. A. Shchuko, et al.
Publicado: (2016)

Subthreshold micropulse yellow laser treatment for nonresolving central serous chorioretinopathy
por: Abd Elhamid AH
Publicado: (2015)

Microsecond yellow laser for subfoveal leaks in central serous chorioretinopathy
por: Ambiya V, et al.
Publicado: (2016)

GRADED CRITERIA OF DIAGNOSTICS AND PREDICTION OF CENTRAL SEROUS CHORIORETINOPATHY OUTCOME
por: A. G. Shchuko, et al.
Publicado: (2016)

Modified Low Power Mode Laser for the Treatment of Central Serous Chorioretinopathy
por: Miura M, et al.
Publicado: (2020)

Neovascular age-related macular degeneration without drusen in the fellow eye: clinical spectrum and therapeutic outcome
por: Chung WH, et al.
Publicado: (2016)

Treatment of central serous chorioretinopathy with topical NSAIDs
por: Bahadorani S, et al.
Publicado: (2019)

Central Serous Chorioretinopathy in Elderly Patients Mimicking Occult Neovascular Age-Related Macular Degeneration
por: Adrean SD, et al.
Publicado: (2020)

Combined Technique and Its Clinical and Pathogenetic Evaluation in Treatment of Central Serous Chorioretinopathy Using Subthreshold Microimpulse Laser Irradiation with a Wavelength of 577 nm in Combination with Injections of Platelet Autoplasma
por: O. M. Stanishevskaya, et al.
Publicado: (2019)

Deep Learning for Detecting Subretinal Fluid and Discerning Macular Status by Fundus Images in Central Serous Chorioretinopathy
por: Fabao Xu, et al.
Publicado: (2021)

Predicting Central Serous Chorioretinopathy Recurrence Using Machine Learning
por: Fabao Xu, et al.
Publicado: (2021)

Oral Spironolactone versus Conservative Treatment for Non-Resolving Central Serous Chorioretinopathy in Real-Life Practice
por: Sinawat S, et al.
Publicado: (2020)

Evaluation of Psychophysiological and Hormonal Changes in Acute and Chronic Forms of Central Serous Chorioretinopathy
por: A. A. Shchuko, et al.
Publicado: (2019)

Short Axial Length Is Related to Asymmetric Vortex Veins in Central Serous Chorioretinopathy
por: Nobuhiro Terao, MD, PhD, et al.
Publicado: (2021)

Half-dose photodynamic therapy for serous non-neovascular retinal pigment epithelial detachment
por: Inoda S, et al.
Publicado: (2019)

Choroidal Volume Evaluation after Photodynamic Therapy Using New Optical Coherence Tomography Imaging Algorithm
por: Miki Sato-Akushichi, et al.
Publicado: (2021)

Predicting Post-Therapeutic Visual Acuity and OCT Images in Patients With Central Serous Chorioretinopathy by Artificial Intelligence
por: Fabao Xu, et al.
Publicado: (2021)

Baseline Predictive Factors of Visual Outcome and Persistence of Subretinal Fluid Based on Morphologic Changes in Spectral Domain Optical Coherence Tomography in Patients with Idiopathic Central Serous Chorioretinopathy
por: Suwal B, et al.
Publicado: (2019)

Effective Ocular Delivery of Eplerenone Using Nanoengineered Lipid Carriers in Rabbit Model
por: Abdelhakeem E, et al.
Publicado: (2021)

Features of IgG-antibodies production to individual Cytomegalovirus proteins in various eye diseases (age-related macular degeneration and central serous chorioretinopathy)
por: V. V. Neroev, et al.
Publicado: (2021)

Association of Retinal Vascular Manifestation and Obstructive Sleep Apnea (OSA): A Narrative Review
por: Al Saeed AA, et al.
Publicado: (2021)

Preliminary analysis of the relationship between serum lutein and zeaxanthin levels and macular pigment optical density
por: Fujimura S, et al.
Publicado: (2016)

Effect of intravitreal ranibizumab on serous retinal detachment in branch retinal vein occlusion
por: Dogan E, et al.
Publicado: (2018)

Multiple spots of photodynamic therapy for the treatment of severe chronic central serous chorioretinopathy
por: Tsakonas GD, et al.
Publicado: (2012)

Photoreceptor disruption in central serous chorioretinopathy treated by half-dose photodynamic therapy
por: Ratanasukon M, et al.
Publicado: (2013)

Benign macrocystic serous cystadenoma of the pancreas
por: Selma Erdogan Duzcu, et al.
Publicado: (2021)

Methylene Blue-Based Nano and Microparticles: Fabrication and Applications in Photodynamic Therapy
por: Dong-Jin Lim
Publicado: (2021)

Photodynamic therapy at the treatment of recurrent basal cell skin cancer
por: A. V. Belonogov, et al.
Publicado: (2014)

Macular sensitivity after half-dose verteporfin photodynamic therapy in central serous chorioretinopathy
por: Sanguansak T, et al.
Publicado: (2015)

Microperimetric evaluation of chronic central serous chorioretinopathy after half-dose photodynamic therapy
por: Fujita K, et al.
Publicado: (2012)

Serous borderline ovarian tumors: modern possibilities of ultrasound diagnostics in monitoring the course of the disease after organ-preserving operations
por: Irina I. Davydova, et al.
Publicado: (2021)

Oral mineralocorticoid antagonists for recalcitrant central serous chorioretinopathy
por: Chin EK, et al.
Publicado: (2015)